Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Axovant Gene Therapies Ltd
AXGT

Buy AXGT Stock

AXGT
See AXGT stock price and Buy/Sell Axovant Gene Therapies Ltd with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
AXGT

Axovant Gene Therapies Ltd (AXGT)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Axovant Gene Therapies Ltd (AXGT)

Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. The company was founded on October 31, 2014 and is headquartered in New Y...Read more
Market Cap
$21.13M
1 Year High
$2.95
Volume
7.95k
1 Year Low
$0.23
Price to Earnings Ratio
Open
$0.29
Dividend Rate
High
$0.30
Dividend Yield
Low
$0.29

Community

People who own or watch AXGT stock

AXGT Stock News

AXGT stock rating

What analysts recommend for AXGT stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
2.8

AXGT price target

What analysts think AXGT will be worth
Low $0.23
High $3.95
Current $0.29
Target $3.95

Events

List of events that could affect AXGT stock.
09Feb

Earnings data Q4 2020

10Jun

Earnings data Q1 2021

AXGT earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.12
-0.23
-0.35
Q4 2021
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
-$0.15
Actual EPS
Q3 2022

Buy AXGT Stock

AXGT
See AXGT stock price and Buy/Sell Axovant Gene Therapies Ltd with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch AXGT stock
  • thisisceazar avatar
  • vrindans avatar
  • johnnycash626 avatar
  • Flee avatar
  • Ejr87 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.